Cargando…
Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
BACKGROUND: The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies. In addition, the changes in the use of CAM over the course of treatment are understudied. Thus, this study aimed to explore (1) CAM use by...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977159/ https://www.ncbi.nlm.nih.gov/pubmed/33736643 http://dx.doi.org/10.1186/s12906-021-03271-9 |
_version_ | 1783667084193955840 |
---|---|
author | Lüthi, Emmanuelle Diezi, Manuel Danon, Nadia Dubois, Julie Pasquier, Jérôme Burnand, Bernard Rodondi, Pierre-Yves |
author_facet | Lüthi, Emmanuelle Diezi, Manuel Danon, Nadia Dubois, Julie Pasquier, Jérôme Burnand, Bernard Rodondi, Pierre-Yves |
author_sort | Lüthi, Emmanuelle |
collection | PubMed |
description | BACKGROUND: The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies. In addition, the changes in the use of CAM over the course of treatment are understudied. Thus, this study aimed to explore (1) CAM use by pediatric oncology patients in relation to specific time intervals and (2) communication about CAM use between parents and oncologists. METHODS: This retrospective cross-sectional study was conducted among parents of children diagnosed with cancer at a Swiss pediatric hematology-oncology center by means of an online questionnaire. Questions were related to their child’s CAM use over different time intervals, sources of information about CAM use, and communication with the oncologists. RESULTS: Among 140 respondents, CAM was used by 54.3% of patients before diagnosis and 69.3% of patients after diagnosis. During each defined time interval, between 50 and 58.8% of the patients used at least one CAM. Homeopathy was the most popular CAM modality used during oncology treatment, during the first year after treatment, and between 1 and 5 years after the end of treatment. Osteopathy was the most popular CAM ≥5 years after the end of oncology treatment. Forty percent of respondents did not discuss CAM with their oncologist. CONCLUSIONS: The high prevalence of CAM use and the different trends of use during the oncology care pathway and afterward underline the need to increase communication about CAM in the pediatric oncology setting, notably regarding benefits and risks of interaction with oncology treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03271-9. |
format | Online Article Text |
id | pubmed-7977159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79771592021-03-22 Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment Lüthi, Emmanuelle Diezi, Manuel Danon, Nadia Dubois, Julie Pasquier, Jérôme Burnand, Bernard Rodondi, Pierre-Yves BMC Complement Med Ther Research Article BACKGROUND: The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies. In addition, the changes in the use of CAM over the course of treatment are understudied. Thus, this study aimed to explore (1) CAM use by pediatric oncology patients in relation to specific time intervals and (2) communication about CAM use between parents and oncologists. METHODS: This retrospective cross-sectional study was conducted among parents of children diagnosed with cancer at a Swiss pediatric hematology-oncology center by means of an online questionnaire. Questions were related to their child’s CAM use over different time intervals, sources of information about CAM use, and communication with the oncologists. RESULTS: Among 140 respondents, CAM was used by 54.3% of patients before diagnosis and 69.3% of patients after diagnosis. During each defined time interval, between 50 and 58.8% of the patients used at least one CAM. Homeopathy was the most popular CAM modality used during oncology treatment, during the first year after treatment, and between 1 and 5 years after the end of treatment. Osteopathy was the most popular CAM ≥5 years after the end of oncology treatment. Forty percent of respondents did not discuss CAM with their oncologist. CONCLUSIONS: The high prevalence of CAM use and the different trends of use during the oncology care pathway and afterward underline the need to increase communication about CAM in the pediatric oncology setting, notably regarding benefits and risks of interaction with oncology treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03271-9. BioMed Central 2021-03-18 /pmc/articles/PMC7977159/ /pubmed/33736643 http://dx.doi.org/10.1186/s12906-021-03271-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Lüthi, Emmanuelle Diezi, Manuel Danon, Nadia Dubois, Julie Pasquier, Jérôme Burnand, Bernard Rodondi, Pierre-Yves Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
title | Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
title_full | Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
title_fullStr | Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
title_full_unstemmed | Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
title_short | Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
title_sort | complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977159/ https://www.ncbi.nlm.nih.gov/pubmed/33736643 http://dx.doi.org/10.1186/s12906-021-03271-9 |
work_keys_str_mv | AT luthiemmanuelle complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment AT diezimanuel complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment AT danonnadia complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment AT duboisjulie complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment AT pasquierjerome complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment AT burnandbernard complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment AT rodondipierreyves complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment |